B. Rawson, N. S. (2020) “Regulatory approval and public drug plan listing of new drugs for rare disorders in Canada and New Zealand”, Journal of Population Therapeutics and Clinical Pharmacology, 27(2), pp. e58-e67. doi: 10.15586/jptcp.v27i2.673.